NCT06763601 Effect of Shoulder Symptom Modification Procedure (SSMP) in Managing Patients with Frozen Shoulder
| NCT ID | NCT06763601 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Gulf Medical University |
| Condition | Frozen Shoulder |
| Study Type | INTERVENTIONAL |
| Enrollment | 36 participants |
| Start Date | 2025-01-01 |
| Primary Completion | 2025-03-22 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 36 participants in total. It began in 2025-01-01 with a primary completion date of 2025-03-22.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
the study is about intervention to patient with frozen shoulder to help patients improve function and shoulder disability , reduce pain and improve range of motion, the main aim of this study is to find out which treatment intervention SSMP , MWM and sham mobilization give effective results
Eligibility Criteria
Inclusion Criteria: * • Diagnosis of adhesive capsulitis confirmed by a healthcare professional. * Scores more than 2 in adhesive capsulitis scale * Range of motion affected in capsular pattern * Age between 40-65 years. * Willingness to participate by signing informed consent Exclusion Criteria: * Having any history of shoulder dislocation * Humerus fractures or trauma * Diagnosed with any sort of cancer * History of cardiovascular disease
Contact & Investigator
Frequently Asked Questions
Who can join the NCT06763601 clinical trial?
This trial is open to participants of all sexes, aged 40 Years or older, up to 65 Years, studying Frozen Shoulder. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT06763601 currently recruiting?
Yes, NCT06763601 is actively recruiting participants. Contact the research team at 2023mpt08@mygmu.ac.ae for enrollment information.
Where is the NCT06763601 trial being conducted?
This trial is being conducted at Ajman, United Arab Emirates.
Who is sponsoring the NCT06763601 clinical trial?
NCT06763601 is sponsored by Gulf Medical University. The trial plans to enroll 36 participants.